Breath Therapeutics is a biopharmaceutical company that develops inhalation therapies for severe respiratory diseases. Read more
Breath Therapeutics is a biopharmaceutical company that develops inhalation therapies for severe respiratory diseases. Read more
Co-Founder & CEO
Jens Stegemann
Founded:
2016
Status:
PrivateSubsidiary of Zambon Company S.P.A.
Synairgen is seen as one of Breath Therapeutics's top competitors. Synairgen was founded in 2003, and is headquartered in Southampton, England. Like Breath Therapeutics, Synairgen also competes in the Pharmaceuticals industry. Synairgen generates $3.3M more revenue vs. Breath Therapeutics.
Verona Pharma is a top competitor of Breath Therapeutics. Verona Pharma was founded in 2005, and its headquarters is in London, England. Like Breath Therapeutics, Verona Pharma also competes in the Biotechnology field. Verona Pharma has 32 fewer employees than Breath Therapeutics.
Enterprise Therapeutics is Breath Therapeutics's #3 rival. Enterprise Therapeutics was founded in Brighton, England} in 2014. Like Breath Therapeutics, Enterprise Therapeutics also works within the Pharmaceuticals industry. Compared to Breath Therapeutics, Enterprise Therapeutics generates $4.8M more revenue.
Today 8:35 AM
MarketScreener
No recent acquisitions found related to Breath Therapeutics
Since Breath Therapeutics was founded in 2016, it has participated in 1 round of funding. In total Breath Therapeutics has raised $48.6M. Breath Therapeutics' funding round was on Mar 2017 for a total of $48.6M
No recent investments found related to Breath Therapeutics
